Export Pharmaceuticals to South Korea — duty, demand, documents and buyers

South Korea applies a 8.0% MFN (applied) import duty on Pharmaceuticals (HS 300490) as reported for 2023 to World Bank WITS / UNCTAD TRAINS. A preferential rate of 0.0% (PREF, 2021) is reported for shipments from India. Indian exporters can claim RoDTEP at 0.7% of FOB (DGFT Appendix 4R (RoDTEP schedule)). South Korea imported US$3.86B of this product in 2024, ranking #20 worldwide (OEC World (BACI / UN Comtrade)).

Top importing markets for Pharmaceuticals

• United States — US$75.59B
• Switzerland — US$42.37B
• Germany — US$25.75B
• Belgium — US$20.09B
• Italy — US$15.71B
• China — US$14.01B
• United Kingdom — US$13.07B
• Japan — US$12.49B

Source: OEC World (BACI / UN Comtrade) (2024)

Duty and taxes at destination

• Import duty into South Korea: 8.0% (MFN (applied), 2023, World Bank WITS / UNCTAD TRAINS)
• Preferential rate from India: 0.0% (PREF, 2021)
• India export benefit: RoDTEP 0.7% of FOB (DGFT Appendix 4R (RoDTEP schedule))

Buyer coverage

• Verified buyer coverage for South Korea is being ingested. Import demand above is real; buyer records are published only after screening.

Trade events in this market

• Seoul Food & Hotel — Goyang 2027-06-10

Data sources

• World Bank WITS / UNCTAD TRAINS (as of 2023) — duty
• DGFT Appendix 4R (RoDTEP schedule) (as of 2026-05-01) — exportBenefit
• OEC World (BACI / UN Comtrade) (as of 2024) — demand

Disclaimer: Tariff and incentive figures are the latest officially published rates from the sources shown and may lag the current year. Verify against the destination customs tariff and DGFT notifications before contracting or shipping.

Source

Vametra AI — https://vametra.com/export/pharmaceuticals/to/south-korea